iShares Biotechnology ETF
IBB
iShares Biotechnology ETF IBB Strategy
The investment seeks to track the investment results of the NYSE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
iShares Biotechnology ETF News & Analysis
funds
Are technology funds worth a look?
Like any other investment, you need to know what you own and why.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,567.00 | 12.10 | -0.14% |
| CAC 40 | 7,216.75 | 18.30 | 0.25% |
| DAX 40 | 19,142.46 | 137.68 | 0.72% |
| Dow JONES (US) | 43,760.71 | 352.24 | 0.81% |
| FTSE 100 | 8,149.16 | 64.09 | 0.79% |
| HKSE | 19,601.11 | 103.90 | -0.53% |
| NASDAQ | 18,881.41 | 84.74 | -0.45% |
| Nikkei 225 | 38,026.17 | 326.17 | -0.85% |
| NZX 50 Index | 12,765.24 | 28.18 | 0.22% |
| S&P 500 | 5,928.71 | 11.60 | 0.20% |
| S&P/ASX 200 | 8,323.00 | 3.30 | -0.04% |
| SSE Composite Index | 3,370.40 | 2.41 | 0.07% |